XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 30, 2024
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the three month period ended March 30, 2024 was as follows:

 

   Shares   Weighted Average Grant Fair Value 
Balance, December 30, 2023   1,931,767   $1.65 
Granted   1,164,817    2.68 
Forfeited        
Vested   (20,064)   1.91 
Balance, March 30, 2024   3,076,520   $2.04 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 30, 2024 and April 1, 2023 (no tax benefits were recognized):

  

   Three Months
Ended
   Three Months
Ended
 
   March 30, 2024   April 1, 2023 
Cost of product revenues  $220,605   $26,218 
Research and development   143,823    16,874 
Selling, general and administrative   370,500    151,098 
Total  $734,928   $194,190